Hyun-Jin Kim

Hyun-Jin Kim

Auto-generated profile, based on publicly available information

Hyun-Jin Kim

Department of Psychiatry Chungnam National University Sejong Hospital Sejong Republic of Korea

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 October 2020 in Journal of Medical Internet Research
Verified
Journal Article
Open access
HKHyun-Jin Kim
Hyun-Jin Kim
SLSeulki Lee
Seulki Lee
DJDooyoung Jung
Dooyoung Jung
JHJi-Won Hur
Ji-Won Hur
HLHeon-Jeong Lee
Heon-Jeong Lee
CCChul-Hyun Cho
Chul-Hyun Cho
Background: Social anxiety disorder (SAD) is characterized by excessive fear of negative evaluation and humiliation in social interactions and situations. Virtual reality (VR) treatment is a promising intervention option for SAD.Objective: The purpose of this study was to create a participatory and interactive VR intervention for SAD. Treatment progress, including the severity of symptoms and the cognitive and emotional aspects of SAD, was analyzed to evaluate the effectiveness of the intervention.Methods: In total, 32 individuals with SAD and 34 healthy control participants were enrolled in the study through advertisements for online bulletin boards at universities. A VR intervention was designed consisting of three stages (introduction, core, and finishing) and three difficulty levels (easy, medium, and hard) that could be selected by the participants. The core stage was the exposure intervention in which participants engaged in social situations. The effectiveness of treatment was assessed through Beck Anxiety inventory (BAI), State‐Trait Anxiety Inventory (STAI), Internalized Shame Scale (ISS), Post-Event Rumination Scale (PERS), Social Phobia Scale (SPS), Social Interaction Anxiety Scale (SIAS), Brief-Fear of Negative Evaluation Scale (BFNE), and Liebowitz Social Anxiety Scale (LSAS).Results: In the SAD group, scores on the BAI (F=4.616, P=.009), STAI-Trait (F=4.670, P=.004), ISS (F=6.924, P=.001), PERS-negative (F=1.008, P<.001), SPS (F=8.456, P<.001), BFNE (F=6.117, P=.004), KSAD (F=13.259, P<.001), and LSAS (F=4.103, P=.009) significantly improved over the treatment process. Compared with the healthy control group before treatment, the SAD group showed significantly higher scores on all scales (P<.001), and these significant differences persisted even after treatment (P<.001). In the comparison between the VR treatment responder and nonresponder subgroups, there was no significant difference across the course of the VR session.Conclusions: These findings indicated that a participatory and interactive VR intervention had a significant effect on alleviation of the clinical symptoms of SAD, confirming the usefulness of VR for the treatment of SAD. VR treatment is expected to be one of various beneficial therapeutic approaches in the future.Trial Registration: Clinical Research Information Service (CRIS) KCT0003854; https://cris.nih.go.kr/cris/search/search_result_st01.jsp?seq=13508

16 September 2022 in JMIR Serious Games
Verified
Journal Article
Open access
JCJoo Young Chun
Joo Young Chun
HKHyun-Jin Kim
Hyun-Jin Kim
JHJi-Won Hur
Ji-Won Hur
DJDooyoung Jung
Dooyoung Jung
HLHeon-Jeong Lee
Heon-Jeong Lee
CCChul-Hyun Cho
Chul-Hyun Cho
Background: Social anxiety disorder (SAD) is the fear of social situations where a person anticipates being evaluated negatively. Changes in autonomic response patterns are related to the expression of anxiety symptoms. Virtual reality (VR) sickness can inhibit VR experiences. Objective: This study aimed to predict the severity of specific anxiety symptoms and VR sickness in patients with SAD, using machine learning based on in situ autonomic physiological signals (heart rate and galvanic skin response) during VR treatment sessions. Methods: This study included 32 participants with SAD taking part in 6 VR sessions. During each VR session, the heart rate and galvanic skin response of all participants were measured in real time. We assessed specific anxiety symptoms using the Internalized Shame Scale (ISS) and the Post-Event Rumination Scale (PERS), and VR sickness using the Simulator Sickness Questionnaire (SSQ) during 4 VR sessions (#1, #2, #4, and #6). Logistic regression, random forest, and naïve Bayes classification classified and predicted the severity groups in the ISS, PERS, and SSQ subdomains based on in situ autonomic physiological signal data. Results: The severity of SAD was predicted with 3 machine learning models. According to the F1 score, the highest prediction performance among each domain for severity was determined. The F1 score of the ISS mistake anxiety subdomain was 0.8421 using the logistic regression model, that of the PERS positive subdomain was 0.7619 using the naïve Bayes classifier, and that of total VR sickness was 0.7059 using the random forest model. Conclusions: This study could predict specific anxiety symptoms and VR sickness during VR intervention by autonomic physiological signals alone in real time. Machine learning models can predict the severe and nonsevere psychological states of individuals based on in situ physiological signal data during VR interventions for real-time interactive services. These models can support the diagnosis of specific anxiety symptoms and VR sickness with minimal participant bias. Trial Registration: Clinical Research Information Service KCT0003854; https://cris.nih.go.kr/cris/search/detailSearch.do/13508

1 December 2020 in Neuropsychiatric Disease and Treatment
Verified
Journal Article
Open access
PDF file
ICIk-Seung Chee
Ik-Seung Chee
HKHyun-Jin Kim
Hyun-Jin Kim
YLYoung Lee
Young Lee
JKJee Wook Kim
Jee Wook Kim
Purpose: To examine the relationships of body dysmorphic disorder (BDD) with psychiatric symptoms and quality of life in dermatological patients. Patients and Methods: A total of 154 female patients with dermatological disease underwent a comprehensive clinical assessment that included the Body Dysmorphic Disorder Examination-Self Report (BDDE-SR), Symptom Checklist 90-Revised (SCL-90-R), and Skindex-29. Dermatological disease was categorized as follows: inflammatory dermatoses (reference category), isolated lesions, and unclassified dermatoses. The BDDE-SR and SCL-90-R scores were used to evaluate BDD and psychiatric symptoms, respectively. Dermatological quality of life was measured with the Skindex-29. Results: The BDDE-SR score was significantly associated with the SCL-90-R and Skindex-29 total and subscores, even after controlling for age, body mass index, and dermatological diagnosis. The variables that contributed most to the BDDE-SR score were the SCL-90-R depression score and Skindex-29 emotion scores. Additional analyses revealed that the BDDE-SR score was higher in participants with unclassified dermatoses, but neither the SCL-90-R score nor Skindex-29 score was related to any dermatological diagnosis. Conclusion: The BDD symptoms were especially prominent in the unclassified dermatoses group and were highly related to psychiatric symptoms and a poor quality of life in our dermatological patients. Further research including studies involving psychiatric interviews to confirm the BDD diagnosis and symptoms will improve our understanding of BDD in dermatological patients.

21 July 2022 in Psychiatry Investigation
Verified
Journal Article
Open access
PDF file
YKYe-Won Kang
Ye-Won Kang
TSTai Hui Sun
Tai Hui Sun
GKGa-Yeong Kim
Ga-Yeong Kim
HJHo-Young Jung
Ho-Young Jung
HKHyun-Jin Kim
Hyun-Jin Kim
CCChul-Hyun Cho
Chul-Hyun Cho
In this study, the Search Your Mind (S.Y.M., 心) project aimed to collect prospective digital phenotypic data centered on mood and anxiety symptoms across psychiatric disorders through a smartphone application (app) platform while using both centralized and decentralized research designs: the centralized research design is a hybrid of a general prospective observational study and a digital platform-based study, and it includes face-to-face research such as informed written consent, clinical evaluation, and blood sampling. It also includes digital phenotypic assessment through an application-based platform using wearable devices. Meanwhile, the decentralized research design is a non-face-to-face study in which anonymous participants agree to electronic informed consent forms on the app. It also exclusively uses an application-based platform to acquire individualized digital phenotypic data. We expect to collect clinical, biological, and digital phenotypic data centered on mood and anxiety symptoms, and we propose a possible model of centralized and decentralized research design.

31 July 2020 in JMIR Preprints
Verified
Preprint
Open access
HKHyun-Jin Kim
Hyun-Jin Kim
SLSeulki Lee
Seulki Lee
DJDooyoung Jung
Dooyoung Jung
JHJi-Won Hur
Ji-Won Hur
HLHeon-Jeong Lee
Heon-Jeong Lee
CCChul-Hyun Cho
Chul-Hyun Cho
BACKGROUND Social anxiety disorder (SAD) is characterized by excessive fear of negative evaluation and humiliation in social interactions and situations. Virtual reality (VR) treatment is a promising intervention option for SAD. OBJECTIVE The purpose of this study was to create a participatory and interactive VR intervention for SAD. Treatment progress, including the severity of symptoms and the cognitive and emotional aspects of SAD, was analyzed to evaluate the effectiveness of the intervention. METHODS In total, 32 individuals with SAD and 34 healthy control participants were enrolled in the study through advertisements for online bulletin boards at universities. A VR intervention was designed consisting of three stages (introduction, core, and finishing) and three difficulty levels (easy, medium, and hard) that could be selected by the participants. The core stage was the exposure intervention in which participants engaged in social situations. The effectiveness of treatment was assessed through Beck Anxiety inventory (BAI), State‐Trait Anxiety Inventory (STAI), Internalized Shame Scale (ISS), Post-Event Rumination Scale (PERS), Social Phobia Scale (SPS), Social Interaction Anxiety Scale (SIAS), Brief-Fear of Negative Evaluation Scale (BFNE), and Liebowitz Social Anxiety Scale (LSAS). RESULTS In the SAD group, scores on the BAI (F=4.616, P=.009), STAI-Trait (F=4.670, P=.004), ISS (F=6.924, P=.001), PERS-negative (F=1.008, P<.001), SPS (F=8.456, P<.001), BFNE (F=6.117, P=.004), KSAD (F=13.259, P<.001), and LSAS (F=4.103, P=.009) significantly improved over the treatment process. Compared with the healthy control group before treatment, the SAD group showed significantly higher scores on all scales (P<.001), and these significant differences persisted even after treatment (P<.001). In the comparison between the VR treatment responder and nonresponder subgroups, there was no significant difference across the course of the VR session. CONCLUSIONS These findings indicated that a participatory and interactive VR intervention had a significant effect on alleviation of the clinical symptoms of SAD, confirming the usefulness of VR for the treatment of SAD. VR treatment is expected to be one of various beneficial therapeutic approaches in the future. CLINICALTRIAL Clinical Research Information Service (CRIS) KCT0003854; https://cris.nih.go.kr/cris/search/search_result_st01.jsp?seq=13508

30 June 2022 in Journal of the Korea Academia-Industrial cooperation Society
Verified
Journal Article
Open access
MKMin-Gyu Kim
Min-Gyu Kim
HKHyun-Jin Kim
Hyun-Jin Kim
본 연구의 목적은 코로나바이러스감염증-19(COVID-19) 팬데믹으로 인한 개인의 건강정보의 필요도와 팬데믹의 인지된 영향이 COVID-19 감염과 유사한 신체증상과 우울감으로 이어지는 매개효과를 검증하였다. 본 연구는 COVID-19와 관련된 요인들이 부정적인 정신건강(우울)에 미치는 관계를 알아보기 위해 건강신념모델을 이용하였다. 온라인 수집(2020.12~2022.2)을 통해 총 272 사례가 최종분석되었으며, 매개효과검증을 위해 SPSS PROCESS Macro model 6을 이용하였다. 주요변수로 COVID-19 감염과 유사한 신체적 증상, 건강정보의 필요도, COVID-19 팬데믹의 인지된 영향, 우울 척도를 사용하였다. 연구결과는 다음과 같다. 첫째, 신체적 증상 평균 4.24개, 건강정보 필요도 평균 5.41개, COVID-19 팬데믹의 인지된 영향 평균 25.85점, 우울은 평균 12.18점으로 나타났다. 둘째, 상관분석 결과 변수 간 통계적으로 유의미한 상관이 있었다(p<.01). 셋째, 건강정보의 필요도와 COVID-19 팬데믹의 인지된 영향은 신체적 증상 및 우울 관계를 매개하였다(b=.12, b=.26, b=.07). 이는 정확하지 않은 COVID-19관련 정보들은 팬데믹의 인지된 영향을 높여 개인의 우울감을 높일 수 있다. 개인의 우울감을 낮추기 위해 COVID-19 유사 신체적 증상에 대하여 신뢰할 수 있는 기관의 명확한 정보제공과 빠른 검사와 진단, 우울증 감소/예방을 위한 원격 정신건강 진료를 실시하는 것이 필요하다. 연구결과를 기반으로 제언과 연구의 제한점에 대하여 논의하였다.